 |
|
| Blog results | Results 1 - 10 of about 413 for enteric coated naproxen. (0.26 seconds) |
| Sorted by relevance Sort by date |
| 28 Oct 2009 Subjects in each study were randomized to receive either VIMOVO/E20 (enteric-coated naproxen 500 mg/IR esomeprazole 20 mg) tablets twice-daily or EC naproxen 500 mg twice-daily, over a six-month treatment period. ... AZ US news feed - http://www.astrazeneca-us.com/ [ More results from AZ US news feed ] |
| 18 Oct 2009 AstraZeneca and POZEN Inc. have submitted a Marketing Authorisation Application (MAA) in the European Union via the Decentralised Procedure (DCP) for VIMOVO™ (enteric-coated naproxen/immediate release esomeprazole magnesium, ... PharmaNews.eu - http://www.pharmanews.eu/component/content/frontpage |
| 16 Oct 2009 AstraZeneca and POZEN Inc. today announced that they have submitted a Marketing Authorisation Application (MAA) in the European Union via the Decentralised Procedure (DCP) for VIMOVO™ (enteric-coated naproxen/immediate release ... AstraZeneca News Feed - http://www.astrazeneca.com/ [ More results from AstraZeneca News Feed ] |
| 20 Oct 2009 by Loulith Galenzoga VIMOVO is an investigational product under co-development by AstraZeneca and POZEN, Inc. that combines enteric coated naproxen (an NSAID) with immediate release esomeprazole, a proton pump inhibitor (PPI). VIMOVO is under investigation ... zikkir - http://zikkir.com/health/ |
| 28 Oct 2009 by vitalstocks Vimovo is a fixed-dose combination of enteric-coated naproxen with an immediate release esomeprazole. Given the high risk for gastrointestinal side-effects for patients with OA and RA that take naproxen, roughly 60%, and the lingering ... Stock Blog Hub - http://www.stockbloghub.com/ |
| 22 Jul 2009 by admin my mum got a tablet called 'naproxen enteric coated', she read the leaflet and then she got to the side-effects part. side effects: upset stomach, nausea, vomiting, heartburn, headache, diarrhea, constipation, drowsiness, and dizziness ... Stop Ear Ringing Tinnitus - http://stopearringing.net/ |
| 1 Sep 2009 Vimovo is a fixed-dose combination of enteric-coated naproxen, a pain-relieving non-steroidal anti-inflammatory drug (NSAID) and immediate release esomeprazole, a proton pump inhibitor (PPI), under investigation for the treatment of the ... Drugs.com - New Drug Applications - http://www.drugs.com/new-drug-applications.html [ More results from Drugs.com - New Drug Applications ] |
| 6 Sep 2009 by PharmaBot grade fish oil capsules; enteric coated pharmaceutical grade fish oil capsules; pn 400 phase iii studies show clinically meaningful benefit in reducing gastric ulcers compared to enteric-coated naproxen. Pinoy Pharmacy - http://www.pinoypharmacy.com/blog/ [ More results from Pinoy Pharmacy ] |
| 31 Aug 2009 Pozen announced that a New Drug Application (NDA) for Vimovo (formerly PN 400), a fixed-dose combination tablet containing enteric-coated naproxen and immediate-release esomeprazole, has been filed and accepted for review by the FDA for ... Latest articles from MPR - http://www.empr.com/ [ More results from Latest articles from MPR ] |
| 30 Jun 2009 PN400 is a fixed-dose combination of enteric coated naproxen and immediate release esomeprazole. The proposed trade name is VIMOVO, pending regulatory approval. Upon the FDA's notification of acceptance of the NDA filing for PN400, ... World Pharma News - http://www.worldpharmanews.com/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
